Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

piRNA - Piwi-interacting RNAs02:57

piRNA - Piwi-interacting RNAs

7.2K
PIWI-interacting RNAs, or piRNAs, are the most abundant short non-coding RNAs. More than 20,000 genes have been found in humans that code for piRNAs while only 2000 genes have been found for miRNAs. piRNAs can act at the transcriptional and post-transcriptional levels and have a vital role in silencing transposable elements present in germ cells. They are also involved in epigenetic silencing and activation. Previously, they were thought to function only in germ cells but new evidence suggests...
7.2K
Riboswitches01:56

Riboswitches

9.0K
Riboswitches are non-coding mRNA domains that regulate the transcription and translation of downstream genes without the help of proteins. Riboswitches bind directly to a metabolite and can form unique stem-loop or hairpin structures in response to the amount of the metabolite present. They have two distinct regions – a metabolite-binding aptamer and an expression platform.
The aptamer has high specificity for a particular metabolite which allows riboswitches to specifically regulate...
9.0K
RNA Interference01:23

RNA Interference

27.0K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
27.0K
Bacterial RNA Polymerase00:43

Bacterial RNA Polymerase

31.5K
Unlike eukaryotes, bacteria use a single RNA Polymerase (RNAP) to transcribe all genes. The different subunits of bacterial RNAPhave distinct functions. The multisubunit structure of the bacterial RNAP helps the enzyme to maintain catalytic function, facilitate assembly, interact with DNA and RNA, and self-regulate its activity.
In most genes, the transcription site is a single base present upstream of the coding sequence. Though RNAP is a catalytically efficient enzyme, it does not recognize...
31.5K
RNA Editing02:23

RNA Editing

9.4K
RNA editing is a post-transcriptional modification where a precursor mRNA (pre-mRNA) nucleotide sequence is changed by base insertion, deletion, or modification. The extent of RNA editing varies from a few hundred bases, in mitochondrial DNA of trypanosomes, to a just single base, in nuclear genes of mammals. Even a single base change in the pre-mRNA can convert a codon for one amino acid into the codon for another amino acid or a stop codon. This type of re-coding can significantly affect the...
9.4K
Leaky Scanning02:28

Leaky Scanning

5.4K
During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA.  Marilyn Kozak discovered that the sequence RCCAUGG (where R...
5.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Corrigendum to "Bioenergetic benefits and therapeutic potential of storable mitochondria" [Biochem. Biophys. Res. Commun. 828 (2026) 154119].

Biochemical and biophysical research communications·2026
Same author

Bioenergetic benefits and therapeutic potential of storable mitochondria.

Biochemical and biophysical research communications·2026
Same author

Antenatal Magnesium Sulfate for Tocolysis and Early Enteral Feeding in Preterm Infants: A Retrospective Cohort Study.

Pediatrics international : official journal of the Japan Pediatric Society·2026
Same author

Proteomic profiling identifies circulating soluble MCAM/CD146 as a candidate biomarker for abnormal semen parameters in male infertility.

Annals of clinical biochemistry·2026
Same author

Postmortem MRI detection of a dentate nucleus lesion of uncertain significance in a death with suspected heat exposure.

Legal medicine (Tokyo, Japan)·2026
Same author

Decision-Making Regarding the Administration of Live Vaccines to Patients With a FOXN1 Heterozygous Missense Variant.

Pediatrics international : official journal of the Japan Pediatric Society·2026

Related Experiment Video

Updated: Nov 10, 2025

Sequence-specific and Selective Recognition of Double-stranded RNAs over Single-stranded RNAs by Chemically Modified Peptide Nucleic Acids
09:04

Sequence-specific and Selective Recognition of Double-stranded RNAs over Single-stranded RNAs by Chemically Modified Peptide Nucleic Acids

Published on: September 21, 2017

9.7K

Inchworm-type PNA-PEG conjugate regulates gene expression based on single nucleotide recognition.

Yusuke Hamashita1, Takahiro Shibata1, Akiko Takeuchi1

  • 1Department of Chemistry and Biotechnology, Graduate School of Engineering, Tottori University, 4-101 Koyama-Cho Minami, Tottori 680-8552, Japan.

International Journal of Biological Macromolecules
|April 2, 2021
PubMed
Summary

Artificial nucleic acids called inchworm-type PNA-PEG conjugates (i-PPc) effectively suppress gene expression by targeting specific mRNA sequences. This technology shows promise for antisense therapy, particularly for single nucleotide polymorphisms (SNPs).

Keywords:
AntisenseGene expressionNucleic acid medicinePeptide nucleic acidPolyethylene glycolSingle nucleotide polymorphism

More Related Videos

In Situ Detection of Ribonucleoprotein Complex Assembly in the C. elegans Germline using Proximity Ligation Assay
08:56

In Situ Detection of Ribonucleoprotein Complex Assembly in the C. elegans Germline using Proximity Ligation Assay

Published on: May 5, 2020

6.1K
RNAi Mediated Gene Knockdown and Transgenesis by Microinjection in the Necromenic Nematode Pristionchus pacificus
06:57

RNAi Mediated Gene Knockdown and Transgenesis by Microinjection in the Necromenic Nematode Pristionchus pacificus

Published on: October 16, 2011

16.8K

Related Experiment Videos

Last Updated: Nov 10, 2025

Sequence-specific and Selective Recognition of Double-stranded RNAs over Single-stranded RNAs by Chemically Modified Peptide Nucleic Acids
09:04

Sequence-specific and Selective Recognition of Double-stranded RNAs over Single-stranded RNAs by Chemically Modified Peptide Nucleic Acids

Published on: September 21, 2017

9.7K
In Situ Detection of Ribonucleoprotein Complex Assembly in the C. elegans Germline using Proximity Ligation Assay
08:56

In Situ Detection of Ribonucleoprotein Complex Assembly in the C. elegans Germline using Proximity Ligation Assay

Published on: May 5, 2020

6.1K
RNAi Mediated Gene Knockdown and Transgenesis by Microinjection in the Necromenic Nematode Pristionchus pacificus
06:57

RNAi Mediated Gene Knockdown and Transgenesis by Microinjection in the Necromenic Nematode Pristionchus pacificus

Published on: October 16, 2011

16.8K

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Antisense Technology

Background:

  • Gene expression regulation is crucial for cellular function.
  • Developing targeted nucleic acid therapies for genetic mutations is an active research area.
  • Peptide nucleic acid (PNA) conjugates offer potential for enhanced nucleic acid-based therapeutics.

Purpose of the Study:

  • To synthesize and evaluate an inchworm-type PNA-PEG conjugate (i-PPc) for gene expression suppression.
  • To assess the specificity and efficacy of i-PPc in targeting mRNA sequences, including single nucleotide mutations.
  • To explore the potential of i-PPc as a therapeutic agent for conditions involving single nucleotide polymorphisms (SNPs).

Main Methods:

  • Synthesis of an inchworm-type PNA-PEG conjugate (i-PPc) with specific chemical structures.
  • Testing i-PPc variants targeting different regions of luciferase mRNA in a cell-free protein synthesis system.
  • Evaluating gene expression suppression levels by measuring luciferase production.
  • Analyzing thermodynamic parameters to understand the mechanism of single nucleotide recognition.

Main Results:

  • An i-PPc variant targeting the luciferase start codon (i-PPc_ATGFM) suppressed ~85% of protein production.
  • A single base mutation in the i-PPc (i-PPc_ATGMM) significantly reduced suppression to ~15%, demonstrating high specificity.
  • The i-PPc demonstrated superior gene silencing compared to block-type conjugates or PNA oligos.
  • Thermodynamic analysis indicated that i-PPc's PNA segments contribute to precise single nucleotide recognition.

Conclusions:

  • Inchworm-type PNA-PEG conjugates (i-PPc) are effective in sequence-specific gene expression suppression.
  • The i-PPc exhibits high fidelity in recognizing single nucleotide differences, crucial for targeting SNPs.
  • This novel i-PPc technology holds significant potential for the development of advanced antisense therapies.